Frontlight ResearchEarly access
Not yet recruitingPhase 3
MAGNEFFICIENT: A prospective, randomized, double-blind, placebo-controlled, single-center clinical trial.
Key facts
- Who runs it
- Henry Dunant Hospital Center
- Where
- Greece1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 500 people, planned
- Started
- 1 Sept 2025
- Expected to end
- 1 Mar 2028
- Type of study
- Interventional
- Record updated
- 22 October 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adults aged 18–90 years scheduled for total thyroidectomy
- With or without lymph node dissection, for any benign or malignant indication
- Able to provide written informed consent
- No history of parathyroid disorder or calcium/magnesium metabolism disorder
Who cannot take part
- Active malabsorption syndromes
- Renal insufficiency (eGFR <60 mL/min)
- Current or chronic use of magnesium supplementation
- Medications affecting calcium/magnesium (e.g., diuretics)
- Known intolerance to magnesium therapy
- Patients with comorbidities potentially exacerbated by magnesium supplementation, including: • Cardiac arrhythmias (e.g., AV block, bradyarrhythmias) • Myasthenia gravis • Severe gastrointestinal disorders affecting absorption (e.g., active IBD) • History of hypermagnesemia or magnesium toxicity • Concurrent use of medications with known magnesium interactions (e.g., aminoglycosides, digoxin, bisphosphonates, proton pump inhibitors)
- Pre-existing hypoparathyroidism or hyperparathyroidism
- Unwillingness to comply with study visits or procedures
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To determine whether 8-day oral magnesium aspartate (243 mg/day) reduces chronic postoperative hypoparathyroidism at 6 months.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- The "MAGNEFFICIENT" Prospective Trial: Preoperative Administration of MAGNesium for EFFICIENT Parathyroids after Thyroidectomy
- Record updated
- 22 October 2025